EpiPen MDL Judge Preliminarily Approves $264M Class Settlement
KANSAS CITY, Kan. — The Kansas federal judge overseeing the EpiPen multidistrict litigation on March 11 granted preliminary approval to a $264 million settlement with manufacturer-defendant Mylan N.V. and related entities....To view the full article, register now.
Already a subscriber? Click here to view full article